Masimo (NASDAQ:MASI) Releases FY 2025 Earnings Guidance

Masimo (NASDAQ:MASI - Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share guidance of 5.100-5.400 for the period, compared to the consensus earnings per share estimate of 4.690. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of brokerages have issued reports on MASI. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a report on Wednesday, February 26th. Raymond James lifted their target price on Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a report on Friday, December 27th. Piper Sandler increased their price target on Masimo from $210.00 to $215.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Wells Fargo & Company raised their price target on Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Finally, Stifel Nicolaus reaffirmed a "buy" rating and set a $190.00 price objective (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $194.80.

Masimo Stock Performance

Shares of Masimo stock traded up $1.07 during midday trading on Tuesday, hitting $166.52. The company had a trading volume of 700,207 shares, compared to its average volume of 621,786. The stock has a market cap of $8.98 billion, a price-to-earnings ratio of 114.84 and a beta of 1.04. Masimo has a 12-month low of $101.61 and a 12-month high of $194.88. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50. The company has a fifty day simple moving average of $174.89 and a 200 day simple moving average of $156.55.

Remove Ads

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.38. The business had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. As a group, analysts predict that Masimo will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.